
Tirzepatide produces greater average weight loss than semaglutide — but the right choice depends on your metabolic profile. Our endocrinologist breaks down…

Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist showing up to 24.2% body weight loss in clinical trials. Our endocrinologist explains who is…